FDI medical devices policy to come into effect from Jan 21

Last Updated: Tuesday, January 6, 2015, 15:56

Cabinet last month approved liberalising FDI policy for medical devices sector.

Govt approves 100% FDI in medical devices sector

Last Updated: Wednesday, December 24, 2014, 15:42

Government allowed 100 percent FDI under automatic route in medical devices sector to encourage manufacturing of equipments, including diagnostic kits and other devices.

Cabinet approves 100% FDI for medical devices sector

Last Updated: Wednesday, December 24, 2014, 12:07

Medical devices include wide range of products such as sutures, implants and surgical instruments.

Cabinet to consider easing FDI norms for medical devices biz

Last Updated: Tuesday, December 23, 2014, 21:11

The Union Cabinet is expected to consider Wednesday liberalising foreign direct investment (FDI) policy for the cash-starved medical devices sector.

Kumar calls for policy, regulation shift in Pharma sector

Last Updated: Tuesday, December 23, 2014, 20:57

Calling for a shift in policy and regulation in pharma sector, government Tuesday stressed on the need for pharma industry to make quality medicines available to public at affordable rates.

AstraZeneca-Ranbaxy drug settlement not anti-competitive

Last Updated: Saturday, December 6, 2014, 22:57

In a landmark judgement for pharma sector, a US jury has ruled that AstraZeneca's patent litigation settlement for blockbuster drug Nexium with Ranbaxy was not anti-competitive.

Sun-Ranbaxy deal gets FIPB nod

Last Updated: Monday, December 1, 2014, 18:39

The Sun Pharma-Ranbaxy transaction would create the country's largest pharmaceutical company.

Pharma cos to witness 26% core sales growth in Q3: BoAML

Last Updated: Sunday, January 12, 2014, 15:05

BoAML said it sees strong base business growth at Sun, Dr Reddy, Lupin and Aurobindo Pharma.

Govt retains 100% FDI in existing pharma units

Last Updated: Wednesday, January 8, 2014, 16:18

Government Wednesday decided to retain the policy of allowing 100 percent foreign investment in the existing pharma firms, brushing aside concerns about non- availability of affordable drugs in view of MNCs takeovers.

FDI in pharma sector jumps 86.5% during April-Oct period

Last Updated: Sunday, January 5, 2014, 11:13

FDI in the pharmaceutical sector jumped by 86.5 percent to USD 1.08 billion during April- October period of the current fiscal amid concerns over continuous mergers and acquisitions of domestic drug makers by multinationals.

KKR to acquire minority stake in Gland Pharma for $200 million

Last Updated: Thursday, November 28, 2013, 14:26

Gland Pharma Limited, a city- based generic injectable drug maker, Thursday announced it has reached an agreement for selling a minority stake to KKR, a leading global investment firm, for about USD 200 million.